LONDON and ARLINGTON, Va., April 19, 2016 -- Willis Towers Watson (NASDAQ:WLTW), a leading global advisory, broking and solutions company, will announce its financial results for the first quarter of 2016 on Friday, May 6, 2016 before the market opens.
The company will host a conference call to discuss its financial results at 9:00 a.m. Eastern Time on May 6, 2016. A live broadcast of the conference call will be available online at the Investor Relations section of www.willistowerswatson.com.
An online replay at www.willistowerswatson.com will be available shortly after the call. A telephonic replay of the call will also be available through May 9, 2016 at 404-537-3406, conference ID 95282409.
ABOUT WILLIS TOWERS WATSON
Willis Towers Watson (NASDAQ:WLTW) is a leading global advisory, broking and solutions company that helps clients around the world turn risk into a path for growth. With roots dating to 1828, Willis Towers Watson has 39,000 employees in more than 120 territories. We design and deliver solutions that manage risk, optimize benefits, cultivate talent, and expand the power of capital to protect and strengthen institutions and individuals. Our unique perspective allows us to see the critical intersections between talent, assets and ideas — the dynamic formula that drives business performance. Together, we unlock potential. Learn more at willistowerswatson.com.
CONTACT INVESTORS Aida Sukys | +1 703 258 8033 | [email protected]


FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand
Italy Fines Apple €98.6 Million Over App Store Dominance
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy 



